Department of Internal Medicine, University of Michigan, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA; Center for Clinical Management and Research, Ann Arbor VA Hospital, 2215 Fuller Road, MS 152, Ann Arbor, MI 48105, USA.
Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway, MS F62, Atlanta, GA 30341, USA.
Drug Alcohol Depend. 2020 Jul 1;212:108061. doi: 10.1016/j.drugalcdep.2020.108061. Epub 2020 May 12.
Since 2010, heroin-related overdoses have risen sharply, coinciding with policies to restrict access to prescription opioids. It is unknown if patients tapered or discontinued off prescription opioids transitioned to riskier heroin use. This study examined opioid prescribing, including long-term opioid therapy (LTOT) and discontinuation, prior to heroin overdose.
We used retrospective longitudinal data from a national claims database to identify adults with an emergency or inpatient claim for heroin overdose between January 2010 and June 2017. Receipt of opioid prescription, LTOT episodes, and discontinuation of LTOT were measured for the period of one year prior to heroin overdose.
We identified 3183 individuals (53.2% age 18-25; 70.0% male) with a heroin overdose (incidence rate 4.20 per 100k person years). Nearly half (42.3%) received an opioid prescription in the prior 12 months, and 10.9% had an active opioid prescription in the week prior to overdose. LTOT at any time in the 12 months prior to overdose was uncommon (12.8%) among those with heroin overdoses, especially among individuals 18-25 years old (3.5%, P < 0.001). LTOT discontinuation prior to overdose was also relatively uncommon, experienced by 6.7% of individuals aged 46 and over and 2.5% of individuals aged 18-25 years (P < 0.001).
Prior to heroin overdose, prescription opioid use was common, but LTOT discontinuation was uncommon and observed primarily in older individuals with the lowest heroin overdose rates. Further study is needed to determine if these prescribing patterns are associated with increased heroin overdose.
自 2010 年以来,与限制处方类阿片类药物获取相关的海洛因过量使用急剧增加。目前尚不清楚患者是否逐渐减少或停止使用处方类阿片转而使用风险更高的海洛因。本研究调查了海洛因过量使用之前的阿片类药物处方情况,包括长期阿片类药物治疗(LTOT)的使用和停药情况。
我们使用来自全国索赔数据库的回顾性纵向数据,确定了 2010 年 1 月至 2017 年 6 月期间因海洛因过量而接受急诊或住院治疗的成年人。在海洛因过量前的一年期间,测量了阿片类药物处方、LTOT 发作和 LTOT 停药的情况。
我们共确定了 3183 例海洛因过量患者(53.2%年龄 18-25 岁;70.0%为男性)(发生率为 4.20/10 万人年)。近一半(42.3%)的患者在过去 12 个月内收到过阿片类药物处方,10.9%的患者在海洛因过量前一周内仍有阿片类药物处方。在海洛因过量前 12 个月内,任何时候接受 LTOT 的患者均较少(12.8%),尤其是年龄在 18-25 岁的患者(3.5%,P < 0.001)。在海洛因过量前,LTOT 停药的情况也相对少见,仅 6.7%的 46 岁及以上患者和 2.5%的 18-25 岁患者经历过 LTOT 停药(P < 0.001)。
在海洛因过量之前,处方类阿片类药物的使用较为常见,但 LTOT 停药较为少见,主要发生在海洛因过量发生率最低的老年患者中。需要进一步研究以确定这些处方模式是否与海洛因过量风险增加有关。